HOME >> BIOLOGY >> NEWS
Gene thwarts some pathogens, gives access to others, could save crops

activity that is characteristic of proteins that act as enzymes. This finding led researchers to believe that these molecules give the early signals needed to set off a relay of biochemical events allowing the plant to fight off the pathogen, Mengiste said.

"Basically the BIK1 protein does this by regulating a plant defense hormone called salicylic acid," he said. "The amount of salicylic acid determines the type and level of a plant's response to the pathogen. This is very important in terms of disease resistance.

"In this paper, we speculate that there is an optimum level of salicylic acid that is required for pathogen defense. When that level is exceeded, in some cases it may promote susceptibility to other pathogens by interfering with other defense strategies of the plants."

The research team first looked at normal plants and then at the BIK1 mutant when they began to study the effect of different hormones on plant growth and pathogen defense, Mengiste said. The scientists were surprised to find that the mutants had reduced primary root growth but increased numbers of root hairs. Along with their other findings, this revelation is leading the scientists to future research.

"It looks like this gene actually links pathogen response to plant growth and development," Mengiste said. "But how a single protein regulates these two processes that are singularly independent, we don't know. That is the main purpose of our future studies.

"We need to figure out the details of how it regulates root growth and the length and amount of root hair. This may have implications in terms of nutrient absorption or total plant biomass."

The answers eventually could lead to increased crop yield and decreased produce loss due to Botrytis and other similar pathogens, he said.

Currently, the gray mold disease caused by Botrytis destroys about 10 percent of the grape crop annually and about 25 percent to 30 percent of tomato and str
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
3-Feb-2006


Page: 1 2 3

Related biology news :

1. Disease damages wheat roots, thwarts water uptake
2. Infectious agent thwarts typical defense mechanisms; Sheds light on immune system function
3. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
4. Brain blood flow gives clues to treating depression
5. Immune system escape hatch gives cancer cells traction
6. Investigating Life in Extreme Environments report gives hints on facts of life
7. 5.9 million award gives UK aging research a new lease on life
8. Neuronal activity gives clues to working memory
9. Study of damaged gene gives insight into causes of mental illness
10. Human pubic lice acquired from gorillas gives evolutionary clues
11. DNA gives new perspectives to understand the mysteries of nature

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene thwarts some pathogens gives access others could save crops

(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: